Rhabdomyosarcoma
📧 Sign up to get email alerts when something new happens for Rhabdomyosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping [Phase 2]
Phase 2 study evaluating Lymphoseek for lymph node mapping in pediatric patients with melanoma or rhabdomyosarcoma (and other solid tumors);…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors [Phase 1, Phase 2]
This completed Phase 1/2 study evaluated the safety and preliminary efficacy of combining surufatinib with gemcitabine in pediatric, adolesc…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) [Phase 2]
Phase 2 pediatric trial of Genistein for various cancers was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) [Phase 1, Phase 2]
Phase 1/2 clinical trial update on NK donor lymphocyte infusion following HLA-haploidentical HSCT; study status completed.
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients [Phase 1, Phase 2]
Clinical trial update on Copanlisib in pediatric patients with relapsed or refractory solid tumors or lymphoma, including neuroblastoma, wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes [Phase 2]
Phase 2 trial evaluating oral regorafenib across selected sarcoma subtypes has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) [Phase 2]
This Phase 2 Pediatric MATCH trial evaluated vemurafenib in children with BRAF V600-mutant relapsed or refractory advanced solid tumors, non…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Indo-cyanine Green (ICG) in Paediatric Oncology MIS [Phase 4]
Phase 4 trial update on using Indo-cyanine Green (ICG) in pediatric oncology, with completed status.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating bempegaldesleukin (BEMPEG) in combination with nivolumab in pediatric and young adult patients with recurrent o…
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children [Phase 2]
Phase 2 clinical trial evaluating radiotherapy combined with Realgar-Indigo Naturalis Formula for pediatric rhabdomyosarcoma.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas [Phase 1, Phase 2]
Phase 1/2 trial evaluating nivolumab with or without ipilimumab in younger patients with recurrent or refractory solid tumors or sarcomas; c…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma [Phase 3]
A Phase 3 trial for localized high-risk rhabdomyosarcoma and rhabdomyosarcoma-like soft tissue sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-05Clinical Trial Update: Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating adavosertib in combination with irinotecan hydrochloride for relapsed or refractory solid tumors in younger patie…
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating eribulin mesilate with irinotecan in children with refractory or recurrent solid tumors has completed with result…
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma [Phase 1, Phase 2]
A phase 1/2 trial evaluating ganitumab (IGF-1R antibody) with dasatinib (SFK inhibitor) in embryonal and alveolar rhabdomyosarcoma was termi…
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS) [Phase 2]
Phase 2 clinical trial update evaluating safety and preliminary activity of eribulin mesylate in pediatric patients with relapsed/refractory…
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating stereotactic body radiotherapy (SBRT) for pulmonary metastases in several pediatric and young adult sarcoma-relat…
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Trial of Afatinib in Pediatric Tumours [Phase 1, Phase 2]
Clinical trial update for afatinib in pediatric neuroectodermal tumors and rhabdomyosarcoma (Phase 1/2) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas [Phase 2]
Phase 2 pilot trial evaluating a tumor-specific peptide vaccine with IL-2, with or without autologous T cell transplantation, in recurrent p…
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed Rhabdomyosarcoma [Phase 2]
Phase 2 trial evaluating vincristine and irinotecan with or without temozolomide in refractory/relapsed rhabdomyosarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma [Phase 2]
Phase 2 trial update for Lorvotuzumab Mertansine in several relapsed/refractory pediatric solid tumors; study completed with results posted …
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI [Phase 2]
Phase 2 clinical trial updating the use of ferumoxytol-enhanced MRI to differentiate bone sarcomas from osteomyelitis.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas [Phase 1, Phase 2]
Pilot study investigating expanded, activated haploidentical natural killer cell infusions for Ewing sarcoma and rhabdomyosarcoma across Pha…
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in Children [Phase 1, Phase 2]
Phase 1/2 trial evaluating radiotherapy combined with apatinib mesylate for childhood rhabdomyosarcoma; efficacy and safety data not yet ava…
-
CLINICAL_TRIALS trial_result · 2018-12-27Clinical Trial Update: Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors [Phase 1, Phase 2]
A pediatric Phase 1/2 study assessed the safety and early activity of weekly nab-paclitaxel in children with recurrent or refractory solid t…